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Abstract 
The human gut contains a dense, complex, and diverse microbial community, comprising 
the gut microbiome. Metagenomics has recently revealed the composition of genes in the 
gut microbiome, but provides no direct information about which genes are expressed or 
functioning. Therefore, our goal was to develop a novel approach to directly identify 
microbial proteins in fecal samples to gain information about what genes were expressed 
and about key microbial functions in the human gut. We used a non-targeted, shotgun 
mass spectrometry-based whole community proteomics, or metaproteomics, approach for 
the first deep proteome measurements of thousands of proteins in human fecal samples, 
thus demonstrating this approach on the most complex sample type to date. The resulting 
metaproteomes had a skewed distribution relative to the metagenome, with more proteins 
for translation, energy production, and carbohydrate metabolism compared to what was 
earlier predicted from metagenomics. Human proteins, including antimicrobial peptides, 
were also identified, providing a non-targeted glimpse of the host response to the 
microbiota. Several unknown proteins represented previously undescribed microbial 
pathways or host immune responses, revealing a novel complex interplay between the 
human host and its associated microbes.  
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Introduction 
The human gastrointestinal (GI) tract is host for myriads of microorganisms 
(approximately 1011/gram feces) that carry out vital processes for normal digestive 
functions of the host and play an important, although not yet not fully understood, role in 
maturation of human immunity and defense against pathogens. Recent findings suggest 
that each human has a unique and relatively stable gut microbiota, unless disrupted by 
external factors such as antibiotic treatment (Jernberg et al., 2007). Increasing evidence 
suggests that the composition of the GI microbiota is linked to inflammatory bowel 
diseases (Peterson et al., 2008), such as Crohn’s disease (Dicksved et al., 2008), and can 
even influence the propensity for obesity (Ley et al., 2006). Current estimates based on 
sequencing of 16S rRNA genes in DNA extracted from feces, are that 800-1000 different 
microbial species and >7000 different strains inhabit the GI tract (Bäckhead et al., 2005) 
and that the majority of these (> 80%) have not yet been isolated or characterized 
(Eckburg et al., 2005). Therefore, there is a vast microbial diversity with largely 
unknown function that is waiting to be explored.  
Recently, metagenomic sequencing has revealed information about the complement 
of genes in the gut microbiota of two healthy individuals (Gill et al., 2006). Although this 
data set did not represent the entire GI microbiota, analysis of identified genes revealed 
that the GI microbiome has significantly enriched capacities for glycan, amino acid, and 
xenobiotic metabolism, methanogenesis, and synthesis of vitamins and isoprenoids. This 
indirect evidence suggested that there are unique microbial functions carried out in the 
gut environment. 
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A major limitation of DNA based approaches is that they predict potential functions, 
but it is not known if the predicted genes are expressed at all or if so, under what 
conditions and to what extent. In addition, it is not possible to determine whether the 
DNA is from active viable cells, dormant inactive cells, or even dead cells. These 
limitations can be overcome by directly assessing proteins, because the genes must have 
been transcribed and translated to produce a protein product. However, to date only a 
couple of microbial proteins have been identified from the human gut and these were 
obtained by 2 dimensional polyacrylamide gel electrophoresis (2D PAGE) (Klaassens et 
al., 2007), followed by excision and de novo sequencing of targeted spots on the gel.  
Here, our aim was to develop a novel high throughput, non-targeted mass 
spectrometry (MS) approach to determine the identities of thousands of microbial 
proteins in the most complex sample type to date (i.e. feces) and to test the feasibility of 
using a non-matched metagenome data set for protein identification. This MS-based 
shotgun proteomics approach relies on detection and identification of all proteins in a 
lysed cell mixture without the need for gel based separation or de novo sequencing. 
Instead, the resulting peptides from an enzymatic digest of the entire proteome are 
separated by liquid chromatography and infused directly into rapidly scanning tandem 
mass spectrometers (2D-LC-MS/MS) via electrospray ionization. The resulting peptide 
mass information and tandem mass spectra are used to search against protein databases 
generated from genome sequences. To date, the shotgun metaproteomics approach has 
only been demonstrated in a limited number of studies and only for microbial 
communities with low diversity, such as acid mine drainage systems (Ram et al., 2005; 
Lo et al., 2007), endosymbionts (Markert et al., 2007), and sewage sludge water (Wilmes 
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et al., 2008).  It remains a technical challenge to apply this shotgun approach to more 
complex microbial communities, such as those inhabiting the human gut.  
For this study, it was first necessary to develop the shotgun proteomics approach to 
work with fecal samples containing large amounts of particulate matter and undigested 
food and a large diversity of microbial cells. Figure 1 provides an overview of the 
experimental approach developed. Fecal samples were chosen because sampling is non-
invasive and feces have been shown to provide material that is representative of an 
individual’s colonic microbiota (Eckburg et al., 2005). Our goal was the qualitative 
identification of the range and types of proteins that can be confidently and reproducibly 
measured (i.e. with high specificity and low false positive rates; 1-5% maximum) from 
gut microorganisms by comparing to available metagenome databases (Gill et al., 2006) 
and available gut isolate genomes and to determine if unmatched data sets could suffice 
for accurate protein identifications.  An additional goal was to apply a novel 
bioinformatics approach to assign putative functions to unknown proteins not covered by 
standard analysis of clusters of orthologous groups (COGs). Ultimately, our aim was to 
use the protein data to provide direct evidence of dominant and key microbial functions 
in the human gut for the first time, some of which could serve as indicators of a healthy 
or diseased state. In addition, this non-targeted approach enables identification of human 
proteins associated with the gut microbiota, thus illustrating potential interactions 
between the human microbiome and host. 
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Materials and methods 
Fecal sample collection 
A female healthy monozygotic twin pair born in 1951 was invited to take part in a larger 
double blinded study, and details of these individuals with respect to diet, antibiotic 
usage, etc. are previously described: individuals numbered 6a and 6b (Dicksved et al., 
2008), that provided Samples 7 and 8, respectively, thus were the focus of this study. The 
only differences between the individuals according to the submitted questionnaire data 
were that Individual 6a had gastroenteritis and Individual 6b had taken NSAIDs the last 
12 months. Fecal samples were collected in 20 ml colonic tubes by the twins and 
immediately sent to Örebro University Hospital on the day of collection, where they were 
placed at –70°C and stored. The Uppsala County Ethics Committee and the ORNL 
human study review panel approved the study.  
 
Microbial cell extraction from fecal samples 
Fecal samples were thawed at +4°C and microbial cells were extracted from the bulk 
fecal material by differential centrifugation, as previously described (Apajalahti et al., 
1998). This cell extraction method has previously been found to result in a highly 
enriched bacterial fraction from complex samples, such as soil and chicken feces, with 
negligible bacterial cell loss and a good representation of fecal microbiota (Apajalahti et 
al., 1998). The resulting bacterial cell pellets were immediately frozen at –70°C and 
stored until use. 
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Cell lysis and protein extraction from cell pellets 
The microbial cell pellets (~100 mg) were processed via single tube cell lysis and protein 
digestion. Briefly, the cell pellet was resuspended in 6M Guanidine/10mM DTT to lyse 
cells and denature proteins. The guanidine concentration was diluted to 1M with 50 mM 
Tris buffer/10mM CaCl2 and sequencing grade trypsin (Promega, Madison, WI) was 
added to digest proteins to peptides. The complex peptide solution was desalted via C18 
solid phase extraction, concentrated and filtered (0.45um filter). For each LC-MS/MS 
analyses below, ~1/4 of the total sample was used. 
 
2D-LC-MS/MS 
Both samples were analyzed in technical duplicates via two-dimensional (2D) nano-LC 
MS/MS system with a split-phase column (RP-SCX-RP) (McDonald et al., 2002) on a 
LTQ Orbitrap (Thermo Fisher Scientific) with 22 h runs per sample (LC as previously 
described (Ram et al., 2005; Lo et al., 2007). The Orbitrap settings were as follows: 30K 
resolution on full scans in Orbitrap, all data-dependent MS/MS in LTQ (top five), 2 
microscans for both Full and MS/MS scans, centroid data for all scans and 2 microscans 
averaged for each spectra, dynamic exclusion set at 1.   
 
Proteome informatics 
All MS/MS spectra were searched with the SEQUEST algorithm (Eng et al., 1994) and 
filtered with DTASelect/Contrast (Tabb et al., 2002) at the peptide level [Xcorrs of at 
least 1.8 (+1), 2.5 (+2), 3.5 (+3)]. Only proteins identified with two fully tryptic peptides 
from a 22 h run were considered for further biological study. Tandem MS/MS spectra 
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were searched against four databases, the first database (db1) contained two human 
subject metagenomes (Gill et al., 2006), a human database, and common contaminants.  
The existing metagenome databases (Gill et al., 2006) were deficient in Bacteroides 
sequences and since Bacteroides are known to be common and abundant in the human 
intestine (Eckburg et al., 2005) were also included Bacteroides genome sequences in a 
second database (metadb), plus other sequences from representatives of the normal gut 
microbiota deposited and available at the Joint Genome Institute (JGI) IMG database 
(http//img.jgi.doe.gov/). In addition, we included distracters that one would not 
commonly expect in the healthy gut.  The third and fourth database were made by 
reversing or randomizing the DB1 and appending it on the end of DB1; these databases 
were used primarily for determining false positive rates, as previously described (Lo et 
al., 2007; Peng et al., 2003).  Further descriptions of the databases, searching methods, 
and false positive rates can be found in supplementary information.  All databases, 
peptide and protein results, MS/MS spectra and supplementary tables for all database 
searches are archived and made available as open access via the following link: 
http://compbio.ornl.gov/human_gut_microbial_metaproteome/ 
All MS .raw files or other extracted formats are available upon request. 
 
Hypothetical Protein Prediction 
Hypothetical proteins were submitted to the distant homology recognition server FFAS03 
(Jaroszewski et al., 2005). The list of hypothetical proteins and predicted functions can be 
found in Supplementary Table S11. For 80% of the hypothetical proteins, a statistically 
significant match (Z-score below 9.5) to one of the proteins in the reference databases 
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was obtained. Functions of the matching proteins were used to assign a provisional 
function for the hypothetical proteins identified in this study. All the FFAS03 results are 
available from the FFAS03 server at http://ffas.burnham.org/ffascgi/ cgi/login.pl (Login: 
Janet_new, password: Janet_new). Links provided on the site can be followed to obtain 
detailed alignments, three dimensional models and other information.  
 
Results 
Metaproteomics of fecal samples 
Our results present the first large-scale investigation of the human gut microbial 
metaproteome. The metaproteomes were obtained from two fecal samples (Samples 7 
and 8) collected from two healthy female identical twins (Subjects 6a and 6b, 
respectively, see Dicksved et al. (2008) for a description of the individuals). The shotgun 
approach used enabled us to identify thousands of proteins by matching peptide mass 
data to available isolate genome and metagenome sequence databases (Supplementary 
Table S1). The total number of proteins identified from searching the first database (db1) 
that contained all predicted human proteins and the gut metagenomes, were 1822 
redundant and 1534 non-redundant proteins, with approximately 600 to 900 proteins 
identified per sample and replicate (Table 1).  From the entire non-redundant dataset, 446 
proteins (~1/3) matched human proteins while 1368 (~2/3) matched predicted proteins 
from the microbial metagenome sequence data (Supplementary Table S2 for a complete 
list).  
The second database (metadb) contained all of the sequences in the db1 database 
above, in addition to sequences from representatives of the normal gut microbiota, 
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including strains of Bacteroides, Bifidobacteria, Clostridia, and Lactobacilli, plus human 
pathogens and distracters that one would not commonly expect in the healthy gut, such as 
environmental isolates.  The rice (Oryza Sativa) genome was included to help identify 
plant (food) related proteins. From the metadb, the total number of proteins identified 
were 2911 redundant and 2214 non-redundant; between 970 and 1340 proteins were 
identified per sample and replicate (Table 1). The categorical breakdown of identified 
proteins from each major database type and the complete list is shown in Supplementary 
Table S3.  In three out of four runs, the highest percentage of protein identifications 
corresponded to the bacterial genome sequences that were screened.  In the fourth run 
(i.e. run 2, Sample 8), most protein identifications matched to one of the metagenomes. 
By contrast, 30-35% of spectra matched to the human protein database, most likely due to 
a few highly abundant human proteins in the samples with a large number of spectral 
counts.  The proteins matching to both rice and environmental isolate distracters were 
low, between 2-9%, indicating that the majority of the sequences matched to bacterial 
types and human sequences that one would expect in the human gut environment.  
Among the microbial genomes screened, the highest protein matches were to 
expected sequences from gut isolates. Of the ~10,000-13,000 total spectra observed from 
each run, ~2,000 matched Bacteriodes or Bifidobacterium species, with the Bacteriodes 
species always having slightly more spectra, emphasizing the dominance of these groups 
and their functional significance in the human distal intestine.  This data correlates well 
with our previously published microbial fingerprint data showing an abundance of 
Bacteroides spp. in both of the individuals studied here (Dicksved et al., 2008). 
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By using established methods of reverse database searching (Lo et al., 2007; Peng et 
al., 2003); we estimated a false positive rate at the peptide level of 1-5% for all identified 
peptides depending on the method.  If only those peptides with corresponding high mass 
accuracy measurements (<10 ppm) were considered (80-85% of all identified peptides 
per run), then the rate dropped to 0.05-0.23% (See supplementary material for a complete 
description of false positive rate determinations and associated tables: Supplementary 
tables S4-8, Supplementary Figures S1-2) 
 
COG categories in the gut metaproteome 
The proteins identified from the db1 search were classified into COG categories and 
when compared between the two samples and the two technical runs, the data were 
highly reproducible and consistent (Figure 2).  By comparison to the average 
metagenomes previously published from other individuals (Gill et al., 2006), we found 
that several COG categories were more highly represented in the average microbial 
metaproteomes of the individuals in the present study (Figure 3). The metaproteomes 
were significantly skewed, with a more uneven distribution of COG categories than those 
represented in the average metagenomes. The majority of detected proteins were involved 
in translation, carbohydrate metabolism, or energy production; together representing 
more than 50% of the total proteins in the metaproteome.  In addition, more proteins in 
the metaproteomes were representative of COG categories for post-translational 
modifications, protein folding, and turnover. By contrast, other COG categories were 
under represented in the metaproteomes compared to the metagenomes, including 
 12 
proteins involved in inorganic ion metabolism, cell wall and membrane biogenesis, cell 
division and secondary metabolite biosynthesis.  
 
Label free estimation of relative protein abundance by NSAF 
We estimated the relative abundances of the thousands of proteins that were detected in 
each sample by calculating normalized spectral abundance factors (NSAF) (Florens et al., 
2006; Zybailov et al., 2006). The entire list of proteins sorted by averaged NSAF across 
all samples and technical runs is shown in Supplementary Tables S2-3. By comparing the 
NSAF data from each sample and technical run to each other, it was clear that the 
technical runs were highly reproducible for a given sample; R2 values of 0.77 and 0.85 
for Samples 7 and 8 respectively (Supplementary Figs. S3-4).     
The most abundant proteins based on this prediction were common abundant human 
derived digestive proteins such as elastase, chymotrypsin C, and salivary amylases.  The 
most abundant microbial proteins included those for expected processes, such as enzymes 
involved in glycolysis (e.g. Glyceraldehyde-3-phosphate dehydrogenase). Ribosomal 
proteins (in particular for Bifidobacterium) were also relatively abundant, as were DNA 
binding proteins, electron transfer flavoproteins, and Chaperonin GroEL/GroES (HP60 
family).  
The gut microbiomes previously published (Gill et al., 2006) were enriched for many 
COGs representing key genes in the methanogenic pathway, consistent with H2 removal 
from the distal gut ecosystem via methanogenesis. By contrast, we found very few 
proteins represented by methanogens. One example is a hypothetical protein from 
Methanobrevibacterium found in Sample 8. Instead, analysis of the list of proteins based 
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on the NSAF ranking in our study revealed a high relative abundance of 
formyltetrahydrofolate synthetase (FTHFS), a key enzyme in the acetyl-CoA pathway of 
acetogens (Drake et al., 2008). Acetogenic bacteria utilize H2 to reduce CO2 and form 
acetate. Although methanogenesis is an important H2 disposal route in about 30-50% of 
people in Western countries, in the remainder H2 is consumed by sulfate reduction or 
reductive acetogenesis, and this seems to be the situation for the samples we have studied 
here.  
Similar to the published metagenomes that reported several COGs responsible for 
host-derived fucose utilization that were enriched in the human gut microbiome relative 
to all microbial genomes (Gill et al., 2006), we also found several proteins involved in 
fucose metabolism, including fucose isomerase and propanediol fermentation (later steps 
in the pathway). In particular, we detected proteins corresponding to polyhedral bodies 
that are assumed to protect the cell by sequestering the toxic propionaldehyde 
intermediate of this pathway (Havemann and Bobik, 2003). 
Butyrate kinase was the most highly enriched COG (odds ratio of 9.30) in the 
previous metagenomic study by Gill et al. (2006). This enzyme is the final step in 
butyrate fermentation. Although we did not identify butyrate kinase, we did find that 
butyryl-CoA dehydrogenase had a relatively high abundance based on the NSAF 
analyses.  This enzyme catalyzes one of the previous steps in the same pathway; 
interestingly this protein was strongly expressed in Sample 8 but was not detected in 
Sample 7.  Additional proteins of interest that were relatively abundant included NifU-
like homologs and rubrerythrin. The role of NifU has been proposed as a scaffold protein 
for Fe-S cluster assembly (Ayala-Castro et al., 2008). Rubrerythrin is found in anaerobic 
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sulfate reducing bacteria and is a fusion protein containing an N-terminal iron binding 
domain and a C-terminal domain homologous to rubredoxin. The physiological role of 
rubrerythrin has not been identified, but it has been shown to protect against oxidative 
stress in D. vulgaris and other anaerobic microorganisms (Mukhopadhyay et al., 2007). 
Average NSAF values were compared to determine unique and shared proteins in 
Samples 7 and 8 (Figure 4, metadb database; Supplementary Figure S5, db1 database). 
The scatter plot reveals five distinct areas: proteins found in similar abundances in both 
samples along the diagonal (listed in Supplementary Tables S9-10, 1st tabs), proteins 
found in only one sample on the respective axis, and two distinct lobes that are 
overexpressed in one sample or the other but present in both (Figure 4; data for proteins 
showing significant deviation from central line found in Supplementary Tables S9-10, 2nd 
tabs). We suggest that the group of approximately equally abundant proteins (747 total) 
represent core gut populations and functions, supported by the finding that a high 
proportion of these proteins were from common gut bacteria (i.e. Bacteroides, 
Bifidobacterium and Clostridium) and represented housekeeping functions: translation 
(19%), energy production (14%), post-translational modification and protein turnover 
(12%) and carbohydrate metabolism (16%) (Supplementary Table S10, 1st tab). By 
contrast, the proteins found in only one sample contained proportionately fewer in COG 
categories for housekeeping functions and from common gut species, but a higher 
proportion with unknown functions (28% compared to 11% found in both). These results 
suggest that the proteins present or over represented in only one sample could represent 
bacterial populations and functions that change according to environmental influences, 
such as immediate diet.  For example, 33% of the unique proteins only found in Sample 
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7, are prolamin proteins, i.e. plant storage proteins having a high proline content found in 
seeds of cereals, suggesting recent ingestion of cereal grains by that individual. Although 
these individuals did not specify any particular dietary habits in the questionnaire data 
that accompanied the samples (Dicksved et al., 2008), we do not have any detailed 
information about their specific dietary intake immediately prior to sampling that would 
enable us to verify this finding. 
  
Analysis of unknown-hypothetical proteins 
We performed detailed analyses of the unknown proteins (116 from the published 
metagenomes (Gill et al., 2006) and 89 from bacterial isolate genomes) that could not be 
classified into COG families. The majority of these proteins belong to novel protein 
families that are overrepresented in genomes of gut microbes (Figure 5a). Five of the ten 
most abundant hypothetical proteins in the metaproteome belong to the novel protein 
family represented by hypothetical protein CAC2564 that was previously identified in 
human metagenomes (Gill et al., 2006), while four out of top ten belong to another novel 
protein family represented by a hypothetical protein BF3045 from Bacteroides fragilis.  
Members of both families are present in several Bacteroides, Clostridium, and Vibrio 
species, where they are always associated with each other (see the red and green arrows 
in Figure 5b) and various metabolic enzymes and transport systems. The neighborhood of 
these two proteins resembles a typical amino acid metabolic pathway, and we 
hypothesize that they are involved in amino acid metabolism, most likely cysteine or 
methionine. 
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Another interesting example is the CPE0573 family of hypothetical proteins, 
originally identified in the human gut metagenome (Gill et al., 2006). A distant homolog 
from this family was recently shown to belong to a novel Lacto/galacto-N-biose 
metabolic pathway, identified in Bifidobacterium bifidum (Derensy-Dron et al. 1999) and 
Bifidobacterium longum (Nishimoto and Kitaoka, 2007). Other proteins from this 
pathway were also found in the metaproteome samples, suggesting that it was active in 
our subjects who apparently ingested lactose in their diet.  Additionally, an operon 
formed by a hypothetical protein BT2437 from Bacteroides thetaiotaomicron VPI-5482 
was found which codes for a putative lipoprotein (Cheng et al., 1999). Proteins from this 
family are always associated with channel forming 8-stranded beta-barrel proteins from 
the OprF family (Saint et al., 2000) (Figure 4c).  The list of hypothetical proteins and 
predicted functions can be found in Supplementary Table S11. 
 
Identification of human proteins 
Almost 30% of all identified proteins were human. The two largest groups of human 
proteins identified in our study were digestive enzymes and structural cell adhesion and 
cell-cell interaction proteins. However, the third largest category was comprised of 
human innate immunity proteins, including antimicrobial peptides, scavenger receptor 
cysteine-rich (SRCR) proteins (represented by the DMBT1 (deleted in malignant brain 
tumors) protein), and many other proteins linked to innate immunity and inflammation 
response (intellectin, resistin, and others).   Most of the abundant human proteins were 
similar in the two individuals, but some differences were found in less abundant proteins 
(Supplementary Table S9, DB1_differential tab). 
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We were particularly interested in further investigation of DMBT1 (also called 
salivary agglutinin and glycoprotein-340) that is predominantly expressed in epithelial 
cells and secreted to the lumen. This protein has several proposed beneficial functions 
including tumor suppression, bacterial binding, and anti-inflammatory effects (Ligtenberg 
et al., 2007; Rosensteil et al., 2007). Detailed analysis of the distribution of DBMT1 
peptides shows that they had fairly uniform distribution along the protein, including hits 
from all 17 domains present in the DBMT1 protein (Fig 6), suggesting that the DBMT1 
protein was present in our samples as a complete, intact protein, that we postulate is 
indicative of a healthy gut environment.  
 
Discussion 
This is the first demonstration of an overall method for obtaining metaproteomics 
datasets from complex material, in this case human feces, and successful demonstration 
of the deepest coverage of a complex metaproteome to date. By comparison to previous 
work on natural environmental samples with only a few dominant species (Ram et al., 
2005; Lo et al., 2005; Wilmes et al., 2008), the gut microbiota represents a highly diverse 
community with thousands of species and strain variants. Therefore, we are testing the 
technical limit of the use of a shotgun proteomics approach in this study. We were 
encouraged that the sample extraction and preparation methods worked well for fecal 
samples. Although there remain experimental and computational challenges, the results 
presented here indicate that this general approach will be applicable to other complex 
environments, such as marine and soil microbial communities.  
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We also successfully demonstrated for the first time that it was feasible to use an 
unmatched metagenome dataset to obtain valid protein identifications. It is currently 
more rapid and less expensive to obtain metaproteome data, as we have demonstrated 
here, than metagenome data. Therefore, this finding is promising for future 
metaproteomics studies of other environments that do not have matched metagenomics 
sequence data available. 
One of the challenges we addressed was that of estimating protein abundances in 
these complex samples.  Here we used label free methods based on spectral counting and 
normalized spectral abundance factors (NSAF) (Florens et al., 2006; Zybailov et al., 
2006). NSAF is based on spectral counts but also takes into account protein size and the 
total number of spectra from a run, thus normalizing the relative protein abundance 
between samples. Efforts are still underway to develop better tools and statistics for label 
free methods, such as the absolute protein expression (APEX) method recently developed 
by Lu et al. (2007) that may allow for better statistical comparisons of two data sets. 
However, the APEX method was derived specifically for isolate data and is not 
applicable to complex microbial communities because it requires an estimate of the 
number of expressed proteins in the system and this is not known, for example, in our 
case.  
Although our results present the largest coverage of the human gut microbial 
metaproteome to date, increasing the dynamic range beyond this initial study will be 
necessary in the future to more fully understand the function of the human gut microbiota 
and its interactions with the human host.  Based on results from previous studies (Ram et 
al., 2005) and (VerBerkmoes, unpublished results with artificial mixtures) we are 
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confident that proteins can be detected from populations that represent at least 1% of a 
mixed community. However, the number of proteins detected (dynamic range) 
dramatically decreases from 1000s to 100s of proteins for those populations that are 
present at lower abundances.   One possibility to increase the dynamic range of detection 
would be to enhance the protein separation steps prior to analysis. The trade off for 
increasing the number of separation steps would be the requirement for a greater amount 
of starting material and instrument time.  Enrichment or depletion techniques could also 
be attempted to increase the coverage of community members present at low levels, but 
care must be taken to not effect the proteome during any manipulations.  Increasing 
dynamic range is a clear challenge for all proteomic applications, but particularly so for 
complex microbial communities such as that found in the human gut, and this will be a 
pressing area for research and method development in the future.    
We made several comparisons of our metaproteome data to the existing metagenome 
data (Gill et al., 2006). Some matches could be made between pathways predicted to be 
functioning based on abundant genes detected in the metagenome data to abundant 
proteins we found, such as those involved in fucose and butyrate fermentation. There 
were also some interesting discrepancies, such as the implication of methanogenesis in 
the former study and the apparent lack of methanogenesis in the samples we analyzed. 
Instead, our data suggest that acetogenesis was occurring in our samples, implicating 
different hydrogen scavenging routes in the subjects in the two studies.  
Although about the same percentage of proteins with “unknown function” was found 
in both the metagenomes and the metaproteomes, the metaproteome data provide direct 
proof that such proteins are actually expressed. Overall, 67% of hypothetical proteins 
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identified in this study could be recognized as distant homologs of already characterized 
families, allowing putative function assignments, with most of them further enriching the 
amino acid and carbohydrate metabolism categories, but also including proteins involved 
in cell-cell signaling and active transport of nutrients across bacterial membranes.  Also, 
fold recognition level structure predictions are possible for 55% of them, opening doors 
for modeling and more detailed function analysis.  
There were additional discrepancies between some proteins predicted in the 
metagenomes that were not detected in the metaproteomes and reasons for this include all 
or some of the following: 1) the microbial community compositions and proteins 
produced were different in the different individuals, 2) the proteins were produced, but 
below the dynamic range of detection, 3) they might not have been expressed at 
significant levels at the time of sampling, or 4) the proteins may have mutated to a point 
that they are no longer detected by screening an unmatched metagenome (Denef et al., 
2007). Therefore, although we successfully identified thousands of proteins using an 
unmatched dataset, it would still be very valuable to have matching metagenome and 
metaproteome data from the same samples and this will certainly be achieved via 
ongoing and future initiatives, such as the NIH Human Microbiome Project 
(http://nihroadmap. nih.gov/hmp/) and the European Union Meta-HIT project 
(http://www.international.inra.fr/ press/metahit). Recently, 13 additional human 
metagenome sequences were published from Japan (Kurokawa et al., 2007) and more 
representative genome sequences from commensal gut isolates are currently being 
sequenced (Peterson et al., 2008). Together these represent valuable resources that should 
eventually aid in identification of more proteins from the human gut. 
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 A large proportion of the proteins detected in the samples (approximately 30%) were 
human proteins. This finding can be explained by the method we used to obtain a 
bacterial cell fraction. Differential centrifugation does not result in a pure bacterial 
fraction, but instead one that is highly enriched in bacterial cells compared to human cells 
and particulate matter in the original fecal sample. Any human proteins that adhered to 
the microbial cells would have been collected in the bacterial pellet. Also there are many 
more proteins in human cells than in bacterial cells. Therefore, even a minor 
contamination of the bacterial fraction with human cells could represent a significant 
number of human proteins. In hindsight this was advantageous because it enabled us to 
detect and identify human proteins, such as antimicrobial peptides, that reflect interaction 
between the host and the microbiota.  Furthermore, this highlights the power of this 
technology to distinctly identify both microbial and human proteins in a combined 
mixture.    
In summary, while it is evident that this massive dataset would require substantial 
effort to completely define and characterize, our goal was to develop an approach to 
obtain a first large-scale glimpse of the functional activities of the microbial community 
residing in the human gut. A wealth of information about functional pathways and 
microbial activities could be gleaned from this data, thereby providing one of the first 
views into the complex interplay of human and microbial species in the human gut 
microenvironment. It is clear that proteomics allows us to directly see potential host-
commensal bacterial interactions. While the human immune response is usually described 
in terms of response to infection, it is clear that innate immunity proteins are part of a 
normal gut environment, shaping the gut microflora to the desired shape.  
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Finally, we would also like to point out that all data is freely accessible to the 
scientific community for future analyses and some proteins that we identified can have 
implications as potential biomarkers for human health. 
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Table 1  
Number of protein, peptide, and spectra identifications for Samples 7 and 8 (2 technical 
runs each) using the db1 and metadb databases (see supplementary material). 
db1 database  
Sample ID Protein identifications* 
Peptide 
identifications 
MS/MS 
Spectra 
Peptides between 
10 and -10 
ppm** 
Sample 7, Run 1 634 1886 4069 81.70 
Sample 7, Run 2 722 2253 4440 80.42 
Sample 8, Run 1 974 3021 5829 83.41 
Sample 8, Run 2 983 2948 6131 81.47 
 
metadb database 
Sample 7, Run 1 970 2441 4829 84.47 
Sample 7, Run 2 1098 2977 5364 81.67 
Sample 8, Run 1 1341 3586 6509 84.71 
Sample 8, Run 2 1275 3374 6635 82.92 
*Numbers given are non-redundant identifications 
** Mass accuracy  
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Figure Legends:  
Figure 1. Shotgun metaproteomics approach used to identify microbial proteins in human 
fecal samples. 
Figure 2. Microbial proteins identified from fecal Samples 7 (blue bars) and 8 (yellow 
bars) according to COG functions. Bars represent technical proteome runs 1 and 2. 
Figure 3. Comparison of average COG categories for available human metagenomes and 
metaproteomes. (A) Average COG categories of the two metagenomes from the gut 
microbiota of two individuals from a previous study (Gill et al., 2006) (B) compared to 
average COG categories of the metaproteomes from the gut microbiota of two individuals 
in the present study. 
 
Figure 4. Comparison of relative abundances (NSAF values) of proteins detected in 
Samples 7 and 8. NSAF values for Samples 7 and 8 were averaged amongst their 
individual technical runs and plotted on a log scale.  The dark blue squares represent all 
of the proteins identified in each sample from screening the metadb database.  The 
straight diagonal line represents the location of all proteins that had approximately equal 
expression in both samples.  
 
Figure 5. Detailed analysis of hypothetical proteins identified in human gut 
metaproteome. (A) Protein representation in the genomes of human gut associated 
microbes; scale changes from 1 (only found in human gut microbes) to -1 (never found 
there), 0 represents even distribution. Conserved genomic neighborhoods of the 
 30 
CAC2564 (B) and BT2437 (C) families. Detailed functions of other proteins, identified 
by numbers in the figure, are provided in the supplementary material.  
 
Figure 6. Positions of DMBT1 peptide fragments along the length of the DMBT1 protein 
are shown as blue boxes (figure is not to scale). DBMT1 has a length of 1785 amino 
acids. PFAM domain names: SRCR (Scavenger receptor cysteine-rich domain); CUB 
(from complement C1r/C1s, Uegf, Bmp1) is a domain found in many in extracellular and 
plasma membrane-associated proteins; Zona pellucida, a large, cysteine rich domain 
distantly related to integrins, found in a variety of mosaic eukaryotic glycoproteins, 
usually acting as receptors. 
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Figure 2  
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Figure 6 
 
 
 
 
 
  
Shotgun Metaproteomics of the Human Distal Gut Microbiota 
VerBerkmoes et al.  Supplementary Online Information 
 
All datasets, databases and supplementary data files (spreadsheets in .xls format) can be 
found at http://compbio.ornl.gov/human_gut_microbial_metaproteome 
 
 
 
Proteome informatics 
All MS/MS spectra were searched with the SEQUEST algorithm (Eng et al., 1994 
[(enzyme type, trypsin; Parent Mass Tolerance, 3.0; Fragment Ion Tolerance, 0.5; up to 4 
missed cleavages allowed (internal lysine and arginine residues), and fully tryptic 
peptides only (both ends of the peptide must have arisen from a trypsin specific cut, 
except N and C-termini of proteins)] and filtered with DTASelect/Contrast (Tabb et al., 
2002) at the peptide level [Xcorrs of at least 1.8 (+1), 2.5 (+2) 3.5 (+3)].  Only proteins 
identified with two fully tryptic peptides from a 22 h run were considered for further 
biological study.  Monoisotopic theoretical masses for all peptides identified by 
SEQUEST were generated and compared to observed masses.  Observed high resolution 
masses were extracted from .raw files from the full scan preceding best identified spectra; 
parts per million (ppm) calculations were made comparing each identified peptides 
observed and theoretical mass.  When quality MS/MS spectra didn’t have an observed 
mass (low intensity) a mass of 0 was reported and ppm was calculated as infinity.  
 
Four database searches were performed with the above settings.  The databases are 
outlined in Supplemental Table S1.  The first database (db1) contained two human 
subject’s metagenomes (Gill et al., 2006) a human database, and common contaminants 
such as trypsin, human keratins, etc.  The existing metagenome databases were deficient 
in Bacteroides sequences and since Bacteroides are known to be common and abundant 
in the human intestine (Eckburg et al., 2005) we also included Bacteroides genome 
sequences in a second database (metadb), plus other sequences from representatives of 
the normal gut microbiota deposited and available at the Joint Genome Institute (JGI) 
IMG database (http//img.jgi.doe.gov/), including representatives of Bacteroides, 
Bifidobacteria, Clostridia and Lactobacilli. In addition, we included representative 
human pathogens and included distracters that one would not commonly expect in the 
gut; i.e. environmental bacterial isolates, plus the rice (Oryza Sativa) genome (to help 
identify food-related proteins).  Distracters were uniquely numbered so they could be 
easily extracted and compared with identifications from proteins thought to be associated 
with the human microbiome.  While this is not actually a false positive rate or false 
discovery rate as properly defined it gives an indication of how well the method uniquely 
identifies gut related proteins vs. other protein databases.  See discussion below on false 
discovery rates. 
 
The third and fourth databases were used for estimating false discovery rates on the 
db1 search as previously described (Lo et al., 2007; Peng et al., 2003).  For the third 
  
database (db3), we took the db1 database and precisely reversed each protein entry (i.e., 
n-terminus became c-terminus in each case) and then appended these reversed sequences 
onto the original database.  The same was done for the fourth database (db4), but in this 
case proteins were not reversed but were randomized (Elias et al., 2007).  Proteins with 
the reversed or randomized orientations were given a unique identifier for easy 
extraction.  All databases, peptide and protein results, MS/MS spectra and supplementary 
tables for all database searches are archived and made available as open access via the 
following link: http://compbio.ornl.gov/human_gut_microbial_metaproteome/ 
Raw files are available on request. 
 
False positives  
Currently, there are many ways of estimating error associated with peptide 
identifications.  Until the field of proteomics comes to a conclusion on the proper way of 
reporting proteomic data, different versions will exist (Tabb et al., 2008).  Even the 
semantics of calling it false discovery rates or false positive rates are under debate.  
Below we refer to them as false positive rates based on the publications the formulas 
were derived from.  For this large scale study, false-positive rates were used in order to 
differentiate between true and false peptide identifications rather than false discovery 
rates (FDR).  The overall false-positive rate (FPR) was estimated using the formula: 
false-positive rate = 2[nrev/(nrev + nreal)]*100 where nrev is the number of peptides 
identified from the reverse database and nreal is the number of peptides identified from the 
real database (Peng et al., 2003). A false-positive rate (FPR) was calculated using three 
different database searches.  First, a composite target-decoy database was created with 
the db1 database.  Data analysis consisted of only the forward peptide identification 
except in the calculation of the FPR where both forward (correct) and reverse (false) 
identifications were required (Peng et al., 2003) (Elias et al., 2007).  The data was 
separated based on ppm values that were between +10 and -10 ppm (<±10ppm), values 
that were able to define a charge state for the peptide but were not between + 10 and -10 
ppm (>±10ppm), and values that were unable to properly identify the charge state of the 
full scan peptide mass spectra (unresolved values).  This +10 and -10 ppm division is 
based on earlier research (Lefsrud et al., 2007), with this metaproteome data summarized 
in Supplementary Figures S1 and S2.  The majority of identified peptides have <±10 ppm 
values, accounting for an average of 83.0% of the total peptides (Table S4).  Peptides 
with >±10 ppm accounted for an average of 8.8% over the data set with 8.2% resulting in 
unresolved values (Table S4).   
 
The average ppm for the total identified peptides from the human microbial 
metaproteome data was 33.7 ppm, however when the data was filtered for <±10 ppm this 
value dropped to -4.1 ppm (Table S5). Also, the average delta amu (atomic mass units) 
for the total identified peptides for the human microbial metaproteome data was 0.054 
amu, but this value dropped to -0.006 amu when filtered for <±10 ppm (Table S5).  The 
FPR for the total identified peptides from the human microbial metaproteome data set 
was between 3.17% and 1.18% for both samples and duplicate runs (Table S6) when all 
peptides were considered.  However, when the data was filtered for only those peptides 
with <±10 ppm these values dropped significantly, the highest FPR for filtered data <±10 
ppm was 0.21% and the lowest was 0.05%.   
  
 
A second approach to estimate the error associated with peptide identifications also 
involved using a composite target-decoy database with db1, except in this case each 
protein sequences was randomly shuffled creating a “decoy” database.  The purpose of 
this decoy database was to create a more randomized database by shuffling the amino 
acids of each protein rather than simply reversing the n-terminus and c-terminus.  A 
shuffled database creates more nonsense, thus, reducing the overall chances of making 
false identifications.  Any proteins that are identified with the decoy database indicate 
that the forward peptide is in fact illegitimate.  A FPR can be estimated using a similar 
formula as previously described.  The number of peptides identified from the shuffled 
database is multiplied by 2 and divided by the sum of all shuffled peptides plus forward 
peptides identified from the target database.  A FPR was estimated for both samples and 
runs (Table S7) and as described (Elias et al., 2007) was similar to the rate determined by 
the reverse database method. 
 
We also estimated the false discovery rate in the metadb database search by different 
method.  Here we were interested in seeing the number of unique and total peptides 
identified to known gut isolates, metagenomes, human proteins and rice proteins vs.  
distracter sequences including the genomes of Leptospirillum ferrooxidans, Shewanella 
oneidensis MR-1, Rhodopseudomonas palustris and others.  For the entire list of database 
entries, please visit the website url: 
http://compbio.ornl.gov/human_gut_microbial_metaproteome/databases/ . 
 
The majority of peptides that matched to the distracter database were in fact non-
unique peptides.  These shouldn’t be counted as false peptides since they overlap with 
peptides and proteins from isolates, metagenomes etc that could be in the gut.  Thus we 
only counted unique peptides matching the distracter sequences.  A FPR was estimated 
for both samples per run by comparing the number of total unique peptides from the 
distracter database to both the total unique peptides from the rest of the database and the 
total peptides from the rest of the database by the same equation given above for the other 
two methods of determining FPR.  When only unique peptides were considered a false 
positive rate of 3-5% was found.  When all peptides were considered then a false positive 
rate of ~1% was found.  These results are very similar to the false positive rates 
determined for db1 with the reverse and shuffled methods. 
 
Assigning proteins to COG groups 
To create Figure 2 in the manuscript the JGI IMG/M database was used 
(http://imgweb.jgi-psf.org/cgi-bin/m/main.cgi). This database contains COG information 
for all proteins which we used for COG assignment for bacterial isolates and the human 
gut metagenome sequences.  We found that 37.9% of the proteins could not be assigned 
to COGs when screening the metagenome databases, similar to 34% estimated for the 
existing metagenome data deposited at JGI. Most of these proteins were hypothetical or 
conserved hypotheticals, therefore, they were assigned "S" which is function unknown.  
On the other hand, several known proteins, such as DNA-directed RNA polymerase, did 
not have an assigned COG function.  In these cases, we assigned them based on our own 
knowledge to a COG category and if we did not know, we assigned them to "R" which is 
  
general function prediction only.  For example, we assigned the DNA-directed RNA 
polymerase protein to "K", for transcription.  Supplemental Table S2 and S3 have COG 
entries for all detected microbial proteins. 
 
Proteins found in all replicates and runs 
We extracted the list of all proteins found in each technical replicate and in both 
biological samples, i.e. the “conserved proteins”.  The list for db1 and associated NSAF 
values for each run can be found in supplemental table 9 first tab (474 proteins total), the 
list for metadb and associated NSAF values for each run can be found in supplemental 
table 10 first tab (749 proteins total).   
 
Label free Quantitation methods. 
The label free methods rely on intrinsic values obtained in the course of the experiment 
such as peak intensities or areas of peptides (Old et al., 2005), spectral counts (Liu et al., 
2004) and normalized spectral abundance factors (Florens et al., 2006; Zybailov et al., 
2006) to quantify peptides and thus proteins.  They have grown in popularity due to 
simplicity, cost considerations and the fact they can be used on any sample assuming 
proper experimental design is implemented.  There is strong effort in the proteome 
informatics community to develop better tools and statistics for label free methods 
(Zhang et al., 2006), (Lu et al., 2007).  The absolute protein expression (APEX) method 
recently developed by Lu et al. (2007) may allow for a better statistical comparison of 
two data sets but was derived specifically for isolate data such as E. coli and yeast.  The 
APEX method will not be applicable to complex microbial communities because it 
requires an estimate on the number of proteins being expressed in the system.  This is not 
possible with a complex microbial community from the gut where it’s impossible to 
estimate the number of different cell types, species or total proteins.  Thus, we applied 
simpler methods for protein quantitation based on spectral counts and normalized spectral 
abundance factors (NSAFs).  Unlike spectral counting, NSAF is based on spectral counts 
but takes into account protein size and the total number of spectra from a run, thus 
normalizing the relative protein abundance between samples.  A spectral abundance 
factor (SAF) is first calculated by dividing the number total number of spectral counts for 
each protein by its mass or length.  The NSAFs are then calculated by normalizing each 
SAF to one by dividing by the sum of all SAFs for all protein (Florens et al., 2006; 
Zybailov et al., 2006).  We first compared the NSAF results from all proteins found in 
Samples 7 and 8 using db1 and metadb, but limited ourselves to those that were only 
found in both technical replicates.  As can be seen in Figures S3 and S4 the 
reproducibility of technical runs, based on NSAFs is high with an R2 of 0.77 for Sample 7 
and 0.85 for Sample 8 with the metadb (similar results with db1 not shown).  We then 
averaged the NSAF values for Samples 7 and 8, but left all proteins in the graph to 
determine what was found uniquely in one sample and not the other.  The results from 
this comparison are found in Figure S5 and suggest some proteins that differed 
significantly in expression between the two samples.  The figure indicates four major 
clusters; two clusters are located on each extreme where proteins were found only in one 
individual but not the other.  The other two intermediate clusters were found where 
proteins were present, but expressed in different amounts in comparison with the other 
individual.  We found the cutoff of these clusters to be around a log ratio difference 
  
between 1.1 and 2.4.  Thus, we created a sub-table of those proteins showing large 
differences in expression between the two samples in db1 via those boundaries.  We 
further manually curated the data to only include only those proteins represented by 
identification in the both runs were they were considered “higher protein abundance” as 
well as 2x increase in average spectral counts over the other sample (Supplementary 
Table S9, second tab). In total 225 proteins were found differentially expressed between 
Sample 7 and Sample 8.  This same process was repeated for the metadb dataset.  Again 
there was similar reproducibility in the technical replicates for the two samples (data not 
shown) and a similar trend in the comparison of Samples 7 and 8 (Figure 4 manuscript).  
In total, 308 proteins were found differentially expressed between Sample 7 and Sample 
8 (for metadb Supplementary Table S10, second tab).    
 
Hypothetical Protein Prediction 
Sequences of all hypothetical proteins identified above (116 from the Gill metagenomes 
and 89 from bacterial isolate genomes), were submitted to the distant homology 
recognition server FFAS03 (Jaroszewski et al., 2005).  This server automatically builds a 
sequence profile for the submitted sequences and compares it against a curated library of 
sequence profiles, encompassing several sets of annotated proteins (COG, PDB, PFAM 
and structure determination targets from the JCSG structural genomics center).  In 
independent tests, FFAS03 was shown to consistently outperform PSI-BLAST and other 
distant recognition algorithms.  In Supplementary Table S11 we have summarized results 
of the analysis.  For 80% of the hypothetical proteins a statistically significant match (Z-
score below 9.5) to one of the proteins in the reference databases can be obtained.  
Functions of the matching proteins were used to assign a provisional function for the 
hypothetical proteins identified in this study.  It is important to such analysis can narrow 
down the possible function of the analyzed protein but, because of the distant homology, 
detailed function may have diverged from that of the homolog identified in this analysis.  
More detailed analysis of active site residue conservation and other features is necessary 
for more detailed function assignment.  All the FFAS03 results are available from the 
FFAS03 server at http://ffas.burnham.org/ffas-cgi/cgi/login.pl (Login: Janet_new, 
password: Janet_new).  Links provided on the site can be followed to obtain detailed 
alignments, three dimensional models and other information. 
 
 
 
 
 
  
Figure S4 (manuscript). Supplementary information: 
 
Genome neighborhood analysis was performed and figures were prepared using the 
SEED environment for genome annotations as implemented at the National Microbial 
Pathogen Data Resource project website 
(http://www.nmpdr.org/cur/FIG/wiki/view.cgi/Main/WebHome). Sequences of BF3046 
and BT2437 genes, representing the two families discussed in the text, were compared 
against the Bacteroides fragilis ATCC genome (NCBI Taxonomy Id: 272559).  
 
B) BF3046 conserved genomic neighborhood 
 (1) red  CAC2564 family, as discussed in the text 
 (2) green  new family of hypothetical proteins, as discussed in the text 
 (3) light brown LysR family transcriptional regulator 
 (4) blue  N-succinyltransferase 
 (5) yellow  DNA damage inducible protein 
 (6) aquamarine new family of hypothetical proteins 
 (7) violet  telluride resistance protein 
 (8) dark green multiple antibiotic resistance protein 
 (9) dark brown new family of hypothetical proteins 
 (10) light blue Glycerophosphoryl phosphodiesterase 
 
C) BT2437 conserved genomic neighborhood 
 (1) red  BT2437 family, as discussed in the text 
 (2) green  new family of hypothetical proteins, as discussed in the text 
 (3) brown  tripeptidyl aminopeptidase 
 (4) blue  MarR family transcriptional regulator 
 (5) yellow  Aspartate decarboxylase 
 (6) aquamarine Coenzyme A disulphate reductase 
 
  
Supplementary Tables 
 
Supplementary Table S1. Description of databases that were screened, see website for 
complete breakdown. 
 
Database Sequences included  References 
db1 Metagenome, Individual 7 
Metagenome, Individual 8 
Human proteins 
Gill et al. 2006 
Gill et al. 2006 
 
metadb db1 
Human commensals and pathogens 
Bacteroides 
Bifidobacterium 
Etc. 
Environmental isolates 
Leptospirillum 
Etc. 
Rice (Oryza Sativa) 
 
JGI/IMG 
db3 and db4 db1 in reverse (db3) or random (db4) 
orientation and appended to db1 
 
 
 
 
 
Supplementary Table S2. Protein Identification with NSAF counting from all runs from 
db1. The results from each individual run can be found on the website. 
 
 
Supplementary Table S3. Tab 1: Categorical breakdown of identifications to each 
database type. Tab 2: Protein Identification with NSAF counting from all runs from 
Metadb.  The results from each individual run can be found on the website.   
 
  
 
 
Supplementary Figure S1. PPM Variability Verse XCorr on Forward Peptide Distribution 
from Human Microbial Metaproteome Data (db1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Figure S2. Delta Atomic Mass Units Verse PPM on Forward Peptide 
Distribution from Human Microbial Metaproteome Data. 
 
 
  
 
 
Supplementary Table S4. Identified Forward Peptides from db1 database search. 
 
 Forward Identified Peptides % of Forward Identified Peptides 
Sample ID 
Values 
<±10ppm 
Values 
>±10ppm 
Unresolved 
values 
Values 
<±10ppm 
Values 
>±10ppm 
Unresolved 
values 
Sample 7  
Run1 2316 279 195 83.0% 10.0% 7.0% 
Sample 7  
Run2 2592 275 330 81.1% 8.6% 10.3% 
Sample 8  
Run1 3664 357 309 84.6% 8.2% 7.1% 
Sample 8  
Run2 3397 355 350 82.8% 8.7% 8.5% 
 
  
 
Supplementary Table S5. Average Delta AMU and Average ppm. 
 Average Delta AMU Average ppm 
Sample ID 
Values 
excluding 
unresolved 
values 
Values 
<±10ppm 
Values 
excluding 
unresolved 
values 
Values 
<±10ppm 
Sample 7  
Run1 
0.065 -0.007 46.9 -4.4 
Sample 7  
Run2 
0.041 -0.003 20.5 -2.2 
Sample 8  
Run1 
0.068 -0.008 43.6 -5.2 
Sample 8  
Run2 
0.040 -0.006 24.2 -4.2 
 
  
Supplementary Table S6. Total Identified Peptides, Identified Reverse Peptides and False 
Positive Rate from db1 determined by reverse database method (db3). 
Identified Reverse Peptides False Positive Rate 
Sample 
ID 
Total 
Identified 
Forward 
Peptides 
Values 
<±10ppm 
Values 
>±10ppm 
Unresolved 
values 
Total False 
Positive 
False 
Positive 
<±10ppm 
Sample 7 
Run1 
2790 3 40 2 3.17% 0.21% 
Sample 7 
Run2 
3197 1 14 4 1.18% 0.06% 
Sample 8 
Run1 
4330 4 37 11 2.37% 0.18% 
Sample 8 
Run2 
4102 1 32 7 1.93% 0.05% 
 
  
Supplementary Table S7. Total Identified Peptides, Identified Shuffled Peptides and 
False Positive Rate from Human Microbial Metaproteome Data (db1) determined by 
random database method (db4) 
 
Identified Shuffled Peptides False Positive Rate 
Sample 
ID 
Total 
Identified 
Forward 
Peptides 
Values 
<±10ppm 
Values 
>±10ppm 
Unresolved 
values 
Total False 
Positive 
False 
Positive 
<±10ppm 
Sample 7 
Run1 2789 3 31 1 2.48% 0.21% 
Sample 7 
Run2 3279 3 51 3 3.42% 0.18% 
Sample 8  
Run1 4324 0 42 6 2.20% 0.00% 
Sample 8  
Run2 4230 5 40 3 2.24% 0.23% 
 
  
Supplementary Table S8. Total Identified Distracter Peptides, Identified Gut Peptides and 
False Positive Rate from Human Microbial Metaproteome Data (metadb) 
 
Sample ID 
Unique 
Distracter 
Peptides 
Non-
Unique 
Distracter 
Peptides 
 Unique 
Gut 
Peptides 
Total Gut 
Peptides 
FPR (%) 
unique 
distracter & 
unique gut 
peptides 
FPR (%) 
unique 
distracter & 
total gut 
peptides 
Sample 7 
Run 1 
30 272 1135 5080 5.15 1.17 
Sample 7 
Run 2 
31 184 1436 6036 4.23 1.02 
Sample 8 
Run 1 
31 205 1899 7115 3.21 0.87 
Sample 8 
Run 2 
33 151 1808 6511 3.59 1.01 
 
  
Supplementary Figure S3. Comparison of NSAF values.  Sample 7, run 1 and run 2 
NSAF values are plotted on a log scale.  The dark blue squares represent all of the 
proteins that were identified in both runs from metadb. 
 
 
 
Supplementary Figure S4. Comparison of NSAF values.  Sample 8, run 1 and run 2 
NSAF values are plotted on a log scale.  The dark blue squares represent all of the 
proteins that were identified in both runs from metadb. 
 
 
 
 
  
Supplementary Figure S5. Comparison of NSAF values for Samples 7 and 8. NSAF 
values were averaged amongst two individual technical runs pre sample and plotted on a 
log scale.  The dark blue squares represent all of the proteins identified in each sample 
from db1.  The straight diagonal line is for visualizing the location of all proteins that had 
approximately equal expression in both samples 
 
 
 
 
  
Supplementary Table S9. Tab one Proteins found in both samples and replicates with db1.  Tab 
two proteins showing abundance differences based on NSAF calculations Samples 7 and 8 with 
db1. 
 
Supplementary Table S10. Tab one Proteins found in both samples and replicates with metadb.  
Tab two proteins showing abundance differences based on NSAF calculations Samples 7 and 8 
with metadb. 
 
Supplementary Table S11. All identified hypothetical proteins and predicted functions.  Column 
B is original predicted function, column C is the new computational predicted function.  More 
detailed listing can be found on website. 
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